Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
King LDW. et al, (2024), Cell Rep Med, 5
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
Hou M. et al, (2023), Science Translational Medicine
Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies.
Ko K-T. et al, (2022), Nat Commun, 13